Vangala, D., Ladigan, S., Liffers, S. T., Noseir, S., Maghnouj, A., Götze, T., . . . Hahn, S. A. (2021). Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models. Genome medicine, 13, . https://doi.org/10.1186/s13073-021-00926-7
Chicago-Zitierstil (17. Ausg.)Vangala, Deepak, et al. "Secondary Resistance to Anti-EGFR Therapy by Transcriptional Reprogramming in Patient-derived Colorectal Cancer Models." Genome Medicine 13 (2021). https://doi.org/10.1186/s13073-021-00926-7.
MLA-Zitierstil (9. Ausg.)Vangala, Deepak, et al. "Secondary Resistance to Anti-EGFR Therapy by Transcriptional Reprogramming in Patient-derived Colorectal Cancer Models." Genome Medicine, vol. 13, 2021, https://doi.org/10.1186/s13073-021-00926-7.